Founded in 2010, GeneCapture is an RNA-based diagnostic company focused on developing portable solutions for rapid pathogen identification and antibiotic susceptibility testing. With a core mission to revolutionize point-of-care diagnostics, GeneCapture manufactures medical, surgical, ophthalmic, and veterinary instruments. The company aims to provide healthcare professionals with quick and accurate diagnostic tools to improve patient outcomes and combat antibiotic resistance.
Notable affiliated people include a team of dedicated scientists who drive innovation in the field of RNA diagnostics. GeneCapture has garnered attention from key investors in the medical technology sector. Among its significant achievements is the development of a portable diagnostic device capable of detecting pathogens and determining their antibiotic susceptibility in real-time. This breakthrough has the potential to significantly impact global healthcare by enabling timely and precise treatment decisions.
